Sign In To Continue
You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
The dispute centers around Agilent’s U.S. Patents No. 10,337,001 and 10,900,034, which cover specific chemical modifications to CRISPR guide RNAs, particularly the incorporation of 2'-O-methyl (2'OMe) modifications. T...
Share This Article
Ready-to-post copy includes the article link.
Court Strikes Down Agilent’s CRISPR Patents in Major IP Ruling The dispute centers around Agilent’s U.S. Patents No. 10,337,001 and 10,900,034, which cover specific chemical modifications to CRISPR guide RNAs, particularly the incorporation of 2'-O-methyl (2'OMe) modifications. T... Read the full IIPLA article: https://iipla.org/news/agilent-crispr-patents-invalidated